Table 1.
Total Sample | Women | Men | |
---|---|---|---|
Enrolled people | 152 | 58.82% | 41.18% |
Mean age (± SD)
(min–max) |
43.91 (±12.03) (26–67) |
44.55 (±11.64) (26–67) |
42.81 (±12.61) (26–64) |
Mean SARS-CoV2 antibody response (AU/mL)
(min–max) |
214.51 (min 3.8; max ≥ 400) |
209.23 (min 3.8; max ≥ 400) |
229.02 (min 3.8; max ≥ 400) |
Mean BMI (±SD)
(min–max) |
25.76 (±5.3) (18.82–44.92) |
25.71 (±6.60) (18.82–44.92) |
26.02 (±2.71) (22.86–32.91) |
Comorbidities (%) | 33.33% | 34.61% | 31.58% |
Physical activity at work | |||
Moderate | 42.22% | 44.00% | 36.84% |
Mild/slight | 31.11% | 32.00% | 31.58% |
None | 26.67% | 24.00% | 31.58% |
Intensive physical activity | 31.11% | 11.5% | 61% |
Light physical activity | 46.67% | 42.31% | 55.5% |
Smoking habits | |||
smokers | 22.22% | 23.08% | 22.22% |
former smokers | 13.33% | 7.69% | 21.05% |
Frequency of alcohol consumption | |||
non-drinkers | 54.35% | 69.23% | 36.84% |
occasional drinkers | 23.91% | 19.23% | 31.58% |
moderate drinkers | 21.74% | 7.69% | 31.58% |
Vitamin D (ng/mL)
(min–max) |
23.10 (4.4–60.7) |
23.62 (4.4–60.7) |
21.47 (5.7–36.7) |